Levente Meszaros
Vice President, Preclinical & Translational Science RadioPharm Theranostics
Seminars
Wednesday 12th November 2025
Monoclonal Antibodies: New Opportunities & Translational Dilemmas
2:00 pm
- Optimising biodistribution by target selection and engineering
- Reducing off-target toxicity to improve tolerability
- Selecting the right non-clinical models to demonstrate efficacy and estimate dosimetry
